Similar drugsTo uncover
Dosage form: & nbspsuppositories rectal [based on cocoa butter, based on polyethylene glycol]
Composition:

1 suppository contains:

Tyqveola 500 mg

Excipients: cocoa butter - 1.5 g

Description:

Suppositories from light green to dark green color, cylindrical, with a pointed end. On the longitudinal section there should be no inclusions, an air rod or a funnel-shaped depression is allowed.

Pharmacotherapeutic group:Prostate hyperplasia is a benign treatment of plant origin
ATX: & nbsp
  • Other drugs for the treatment of benign prostatic hyperplasia
  • Pharmacodynamics:

    Anti-inflammatory and reparative. Reduces the proliferation of prostate cells. Eliminates dysuric phenomena in prostatic hyperplasia. Reduces the degree of edema, leukocyte infiltration of the prostate gland, normalizes the secretory function of the epithelium, increases the muscle tonus of the bladder, normalizes the ejaculatory parameters of the prostate gland, reduces pain caused by prostatitis, relieves symptoms of minor or moderate manifestation of dynamic type infravesic obstruction in prostatitis and benign prostatic hyperplasia.Inhibits the synthesis of prostaglandins, which provides anti-inflammatory effect in the treatment of hemorrhoids.

    Indications:

    Hyperplasia of the prostate

    Chronic prostatitis

    Hemorrhoids

    Contraindications:

    Hypersensitivity to the drug.

    Children's age (up to 12 years).

    Pregnancy and lactation:

    Currently, there is no evidence of a negative effect of the drug Tyqveol® suppositories rectal on the body of pregnant women and during lactation

    Dosing and Administration:The suppository is released from the package and injected into the rectum after defecation or enema 1 suppository 1-2 times a day. The course of treatment for benign prostatic hyperplasia. - 1 to 3 months, or short courses of 10 to 15 days for 6 months. When treating hemorrhoids 1 suppository 1-2 times a day from 10 days to 1 month.

    Precautions for use

    There are no restrictions on admission unless otherwise recommended by your doctor.

    Side effects:

    Allergic reactions. Diarrhea.

    Overdose:

    Diarrhea.

    Treatment: symptomatic

    Interaction:

    There was no clinically significant interaction of Tyqveol® with other drugs

    Effect on the ability to drive transp. cf. and fur:The drug does not affect the ability to drive vehicles, mechanisms
    Form release / dosage:Suppositories rectal 500 mg.
    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 5 ° C.

    Keep medicinal product out of the reach of children.

    Shelf life:2 years. Do not use after the expiry date printed on the package
    Terms of leave from pharmacies:Without recipe
    Registration number:P N002321 / 02
    Date of registration:25.06.2008 / 05.11.2013
    The owner of the registration certificate:NGO EUROPA-BIOFARM, CJSC NGO EUROPA-BIOFARM, CJSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp16.02.2016
    Illustrated instructions
      Instructions
      Up